Semin Liver Dis. 2013;33(3):236-247. Focal nodular hyperplasia has no malignant potential and usually remains stable or decreases in size over time. Less than 20% of patients with FNH develop symptoms ...
Smithsonian Magazine on MSN
Surgeons in China Perform First Pig Liver Transplant in Human Patient
For the first time, surgeons have grafted part of a liver from a genetically modified pig onto a human patient’s organ, marking another major advancement for transplant medicine. In a new paper ...
News Medical on MSN
Predictive models identify high-risk liver cancer recurrence
Liver cancer is one of the world's deadliest malignancies, ranking as the third leading cause of cancer-related death.
Please provide your email address to receive an email when new articles are posted on . For lesions of unknown etiology, the ACG recommends multiphasic contrast-enhanced imaging. The ACG recommends ...
Marking a new milestone in the region’s oncology care, Burjeel Cancer Institute (BCI) has successfully performed the UAE’s ...
FITBOOK magazine on MSN
Liver Cancer–Early Signs, Causes, and Treatment
Liver cancer is considered one of the rarer types of cancer in Germany, but the number of new cases is increasing. The ...
"I don't want to scare women about birth control, but I do want to inspire women to be the CEOs of their bodies," 30-year-old Makenzie Hammond told Newsweek. The California-based marketing ...
Focal nodular hyperplasia (FNH) is a lesion found in an otherwise normal liver, and is considered to be parenchyma overgrowth responsive to increased blood flow secondary to vascular malformations.
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback